can glp-1 be used in type 1 diabetes GLP-1s are no longer the "future" of care. They're the present now that 23% of first-line diabetes treatment are GLP-1s. --- just five years, GLP-1s have gone from niche second-line… The role of GLP1 receptor

Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A

It is continuing the development of an oral GIPR antagonist candidate (PF-07976016) in Phase 2, and maintains an earlier-stage obesity pipeline

When safety evidence is limited, a precautionary approach is taken

However, and despite these limitations, SGLT-2 inhibitors or a GLP-1RA with proven CV disease benefit are recommended in patients with type 2 diabetes and CV disease, established kidney disease, or HF [7,8,9,10]

Per the FDA, compounded drugs are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality before marketing